REPORTS

Let’s Pullulate and Expand Your Business

Global Antimalarial Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 09, 2020  |  217 PAGES  |  REPORT CODE: CMM333093
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Antimalarial drugs refer to drugs used to prevent or treat malaria. Malaria makes people sick and fatal through several different degrees of pathological mechanisms. The purpose of treatment is to prevent death or long-term diseases caused by malaria, reduce the incidence of acute diseases, and completely eliminate infections so that they will not relapse.

The report includes analysis of major segments of the global antimalarial market based on product type, application, and region. The report contains market research on different factors, such as market size, market share, industry competition and growth, and other quantitative information. Malaria is a malignant infectious disease with an extremely widespread epidemic and extremely high morbidity and mortality in the world. More than 500 million people are infected each year, and three million patients die. And more than half of the victims are children in Africa. The resistance of plasmodium falciparum resistance to artemisinin is a public health problem that urgently needs to be addressed, threatening the sustainability of the global malaria reduction effort. The delivery of malaria control products such as mosquito nets and insecticides has also hindered the development of the antimalarial market.

According to data from the World Health Organization's World Malaria Report 2019, among the population of the children of receiving antimalarial treatment, children who are treated in public hospitals are more likely to receive artemisinin-based combinations or combination medications slightly higher than formal private hospitals or the informal private sector, therefore, hospital pharmacies have the highest share of antimalarial drugs.

The main factors driving the growth of the antimalarial market include the rising prevalence of malaria in developing countries, which has led to an increase in the demand for antimalarial drugs. In addition, the government's measures to increase health awareness, timely diagnosis and treatment to prevent the development of malaria from severe to death, and research on new antimalarial drugs are some other factors that promote market growth.

The Antimalarial Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The research provides insights for the global Antimalarial Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Antimalarial Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Antimalarial Drug Market Segmentations:

By Players:

  • F Hoffmann-La Roche Ltd

  • Novartis AG

  • GlaxoSmithKline plc

  • Sanofi SA

  • Mayne Pharma Group Limited

  • King Pharmaceuticals, Inc

  • Merck KGaA

  • Alvizia Health Care

  • Bayer

By Types:

  • Plasmodium Falciparum

  • Plasmodium Vivax

  • Plasmodium Malariae

  • Plasmodium Ovale

By End-User:

  • Hospital Pharmacy

  • Retail Pharmacy

  • E-Commerce

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antimalarial Drug Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Antimalarial Drug Market Size and Growth Rate of Plasmodium Falciparum from 2014 to 2026

    • 1.3.2 Global Antimalarial Drug Market Size and Growth Rate of Plasmodium Vivax from 2014 to 2026

    • 1.3.3 Global Antimalarial Drug Market Size and Growth Rate of Plasmodium Malariae from 2014 to 2026

    • 1.3.4 Global Antimalarial Drug Market Size and Growth Rate of Plasmodium Ovale from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Antimalarial Drug Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

    • 1.4.2 Global Antimalarial Drug Market Size and Growth Rate of Retail Pharmacy from 2014 to 2026

    • 1.4.3 Global Antimalarial Drug Market Size and Growth Rate of E-Commerce from 2014 to 2026

    • 1.4.4 Global Antimalarial Drug Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Antimalarial Drug Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Antimalarial Drug Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Antimalarial Drug by Major Types

    • 3.4.1 Antimalarial Drug Market Size and Growth Rate of Plasmodium Falciparum

    • 3.4.2 Antimalarial Drug Market Size and Growth Rate of Plasmodium Vivax

    • 3.4.3 Antimalarial Drug Market Size and Growth Rate of Plasmodium Malariae

    • 3.4.4 Antimalarial Drug Market Size and Growth Rate of Plasmodium Ovale

4 Segmentation of Antimalarial Drug Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Antimalarial Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Antimalarial Drug in Hospital Pharmacy

    • 4.4.2 Market Size and Growth Rate of Antimalarial Drug in Retail Pharmacy

    • 4.4.3 Market Size and Growth Rate of Antimalarial Drug in E-Commerce

    • 4.4.4 Market Size and Growth Rate of Antimalarial Drug in Others

5 Market Analysis by Major Regions

  • 5.1 Global Antimalarial Drug Production Analysis by Major Regions

  • 5.2 Global Antimalarial Drug Consumption Analysis by Major Regions

  • 5.3 Global Antimalarial Drug Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Antimalarial Drug Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Antimalarial Drug Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Antimalarial Drug Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Antimalarial Drug Production, Import, Consumption and Export Analysis

6 Product Commodity of Antimalarial Drug Market in Major Countries

  • 6.1 Top 5 Export Countries in Antimalarial Drug market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Antimalarial Drug market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Antimalarial Drug market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Antimalarial Drug market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Antimalarial Drug market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Antimalarial Drug market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Antimalarial Drug Landscape Analysis

  • 7.1 North America Antimalarial Drug Landscape Analysis by Major Types

  • 7.2 North America Antimalarial Drug Landscape Analysis by Major End-Users

  • 7.3 North America Antimalarial Drug Landscape Analysis by Major Countries

    • 7.3.1 United States Antimalarial Drug Market Volume and Growth Rate

    • 7.3.2 Canada Antimalarial Drug Market Volume and Growth Rate

    • 7.3.3 Mexico Antimalarial Drug Market Volume and Growth Rate

8 Europe Antimalarial Drug Landscape Analysis

  • 8.1 Europe Antimalarial Drug Landscape Analysis by Major Types

  • 8.2 Europe Antimalarial Drug Landscape Analysis by Major End-Users

  • 8.3 Europe Antimalarial Drug Landscape Analysis by Major Countries

    • 8.3.1 Germany Antimalarial Drug Market Volume and Growth Rate

    • 8.3.2 UK Antimalarial Drug Market Volume and Growth Rate

    • 8.3.3 France Antimalarial Drug Market Volume and Growth Rate

    • 8.3.4 Italy Antimalarial Drug Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Antimalarial Drug Market Volume and Growth Rate

    • 8.3.6 Spain Antimalarial Drug Market Volume and Growth Rate

    • 8.3.7 Belgium Antimalarial Drug Market Volume and Growth Rate

    • 8.3.8 Poland Antimalarial Drug Market Volume and Growth Rate

    • 8.3.9 Russia Antimalarial Drug Market Volume and Growth Rate

    • 8.3.10 Turkey Antimalarial Drug Market Volume and Growth Rate

9 Asia Pacific Antimalarial Drug Landscape Analysis

  • 9.1 Asia Pacific Antimalarial Drug Landscape Analysis by Major Types

  • 9.2 Asia Pacific Antimalarial Drug Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Antimalarial Drug Landscape Analysis by Major Countries

    • 9.3.1 China Antimalarial Drug Market Volume and Growth Rate

    • 9.3.2 Japan Antimalarial Drug Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Antimalarial Drug Market Volume and Growth Rate

    • 9.3.4 India Antimalarial Drug Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Antimalarial Drug Market Volume and Growth Rate

    • 9.3.6 South Korea Antimalarial Drug Market Volume and Growth Rate

10 Latin America, Middle East & Africa Antimalarial Drug Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Antimalarial Drug Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Antimalarial Drug Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Antimalarial Drug Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Antimalarial Drug Market Volume and Growth Rate

    • 10.3.2 Brazil Antimalarial Drug Market Volume and Growth Rate

    • 10.3.3 Nigeria Antimalarial Drug Market Volume and Growth Rate

    • 10.3.4 South Africa Antimalarial Drug Market Volume and Growth Rate 

    • 10.3.5 Argentina Antimalarial Drug Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 F Hoffmann-La Roche Ltd

    • 11.1.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Novartis AG

    • 11.2.1 Novartis AG Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 GlaxoSmithKline plc

    • 11.3.1 GlaxoSmithKline plc Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Sanofi SA

    • 11.4.1 Sanofi SA Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Mayne Pharma Group Limited

    • 11.5.1 Mayne Pharma Group Limited Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 King Pharmaceuticals, Inc

    • 11.6.1 King Pharmaceuticals, Inc Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Merck KGaA

    • 11.7.1 Merck KGaA Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Alvizia Health Care

    • 11.8.1 Alvizia Health Care Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Bayer

    • 11.9.1 Bayer Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 88 Figures and 156 Tables)

  • Figure Product Picture

  • Figure Antimalarial Drug Market Size and Growth Rate of Plasmodium Falciparum from 2014 to 2026

  • Figure Antimalarial Drug Market Size and Growth Rate of Plasmodium Vivax from 2014 to 2026

  • Figure Antimalarial Drug Market Size and Growth Rate of Plasmodium Malariae from 2014 to 2026

  • Figure Antimalarial Drug Market Size and Growth Rate of Plasmodium Ovale from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Antimalarial Drug Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

  • Figure Global Antimalarial Drug Market Size and Growth Rate of Retail Pharmacy from 2014 to 2026

  • Figure Global Antimalarial Drug Market Size and Growth Rate of E-Commerce from 2014 to 2026

  • Figure Global Antimalarial Drug Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Antimalarial Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Antimalarial Drug Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Antimalarial Drug

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Antimalarial Drug by Different Types from 2014 to 2026

  • Table Consumption Share of Antimalarial Drug by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Plasmodium Falciparum

  • Figure Market Size and Growth Rate of Plasmodium Vivax

  • Figure Market Size and Growth Rate of Plasmodium Malariae

  • Figure Market Size and Growth Rate of Plasmodium Ovale

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Antimalarial Drug by Different End-Users from 2014 to 2026

  • Table Consumption Share of Antimalarial Drug by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital Pharmacy

  • Figure Market Size and Growth Rate of Retail Pharmacy

  • Figure Market Size and Growth Rate of E-Commerce

  • Figure Market Size and Growth Rate of Others

  • Table Global Antimalarial Drug Production by Major Regions

  • Table Global Antimalarial Drug Production Share by Major Regions

  • Figure Global Antimalarial Drug Production Share by Major Regions in 2014

  • Figure Global Antimalarial Drug Production Share by Major Regions in 2018

  • Figure Global Antimalarial Drug Production Share by Major Regions in 2026

  • Table Global Antimalarial Drug Consumption by Major Regions

  • Table Global Antimalarial Drug Consumption Share by Major Regions

  • Figure Global Antimalarial Drug Consumption Share by Major Regions in 2014

  • Figure Global Antimalarial Drug Consumption Share by Major Regions in 2018

  • Figure Global Antimalarial Drug Consumption Share by Major Regions in 2026

  • Table North America Antimalarial Drug Production, Import, Consumption and Export Analysis

  • Table Europe Antimalarial Drug Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Antimalarial Drug Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Antimalarial Drug Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Antimalarial Drug market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Antimalarial Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Antimalarial Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Antimalarial Drug market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Antimalarial Drug Consumption by Types from 2014 to 2026

  • Table North America Antimalarial Drug Consumption Share by Types from 2014 to 2026

  • Figure North America Antimalarial Drug Consumption Share by Types in 2014

  • Figure North America Antimalarial Drug Consumption Share by Types in 2018

  • Figure North America Antimalarial Drug Consumption Share by Types in 2026

  • Table North America Antimalarial Drug Consumption by End-Users from 2014 to 2026

  • Table North America Antimalarial Drug Consumption Share by End-Users from 2014 to 2026

  • Figure North America Antimalarial Drug Consumption Share by End-Users in 2014

  • Figure North America Antimalarial Drug Consumption Share by End-Users in 2018

  • Figure North America Antimalarial Drug Consumption Share by End-Users in 2026

  • Table North America Antimalarial Drug Consumption by Major Countries from 2014 to 2026

  • Table North America Antimalarial Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Antimalarial Drug Consumption Share by Major Countries in 2014

  • Figure North America Antimalarial Drug Consumption Share by Major Countries in 2018

  • Figure North America Antimalarial Drug Consumption Share by Major Countries in 2026

  • Figure United States Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Antimalarial Drug Consumption by Types from 2014 to 2026

  • Table Europe Antimalarial Drug Consumption Share by Types from 2014 to 2026

  • Figure Europe Antimalarial Drug Consumption Share by Types in 2014

  • Figure Europe Antimalarial Drug Consumption Share by Types in 2018

  • Figure Europe Antimalarial Drug Consumption Share by Types in 2026

  • Table Europe Antimalarial Drug Consumption by End-Users from 2014 to 2026

  • Table Europe Antimalarial Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Antimalarial Drug Consumption Share by End-Users in 2014

  • Figure Europe Antimalarial Drug Consumption Share by End-Users in 2018

  • Figure Europe Antimalarial Drug Consumption Share by End-Users in 2026

  • Table Europe Antimalarial Drug Consumption by Major Countries from 2014 to 2026

  • Table Europe Antimalarial Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Antimalarial Drug Consumption Share by Major Countries in 2014

  • Figure Europe Antimalarial Drug Consumption Share by Major Countries in 2018

  • Figure Europe Antimalarial Drug Consumption Share by Major Countries in 2026

  • Figure Germany Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure France Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Antimalarial Drug Consumption by Types from 2014 to 2026

  • Table Asia Pacific Antimalarial Drug Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Antimalarial Drug Consumption Share by Types in 2014

  • Figure Asia Pacific Antimalarial Drug Consumption Share by Types in 2018

  • Figure Asia Pacific Antimalarial Drug Consumption Share by Types in 2026

  • Table Asia Pacific Antimalarial Drug Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Antimalarial Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Antimalarial Drug Consumption Share by End-Users in 2014

  • Figure Asia Pacific Antimalarial Drug Consumption Share by End-Users in 2018

  • Figure Asia Pacific Antimalarial Drug Consumption Share by End-Users in 2026

  • Table Asia Pacific Antimalarial Drug Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Antimalarial Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Antimalarial Drug Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Antimalarial Drug Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Antimalarial Drug Consumption Share by Major Countries in 2026

  • Figure China Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandAntimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure India Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Antimalarial Drug Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Antimalarial Drug Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Antimalarial Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Antimalarial Drug Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Antimalarial Drug Consumption Share by Major Countries in 2026

  • Figure GCC Countries Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Antimalarial Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

  • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

  • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

  • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

  • Table Company Profile and Development Status of Novartis AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

  • Figure Sales and Growth Rate Analysis of Novartis AG

  • Figure Revenue and Market Share Analysis of Novartis AG

  • Table Product and Service Introduction of Novartis AG

  • Table Company Profile and Development Status of GlaxoSmithKline plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

  • Table Product and Service Introduction of GlaxoSmithKline plc

  • Table Company Profile and Development Status of Sanofi SA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA

  • Figure Sales and Growth Rate Analysis of Sanofi SA

  • Figure Revenue and Market Share Analysis of Sanofi SA

  • Table Product and Service Introduction of Sanofi SA

  • Table Company Profile and Development Status of Mayne Pharma Group Limited

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mayne Pharma Group Limited

  • Figure Sales and Growth Rate Analysis of Mayne Pharma Group Limited

  • Figure Revenue and Market Share Analysis of Mayne Pharma Group Limited

  • Table Product and Service Introduction of Mayne Pharma Group Limited

  • Table Company Profile and Development Status of King Pharmaceuticals, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of King Pharmaceuticals, Inc

  • Figure Sales and Growth Rate Analysis of King Pharmaceuticals, Inc

  • Figure Revenue and Market Share Analysis of King Pharmaceuticals, Inc

  • Table Product and Service Introduction of King Pharmaceuticals, Inc

  • Table Company Profile and Development Status of Merck KGaA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

  • Figure Sales and Growth Rate Analysis of Merck KGaA

  • Figure Revenue and Market Share Analysis of Merck KGaA

  • Table Product and Service Introduction of Merck KGaA

  • Table Company Profile and Development Status of Alvizia Health Care

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alvizia Health Care

  • Figure Sales and Growth Rate Analysis of Alvizia Health Care

  • Figure Revenue and Market Share Analysis of Alvizia Health Care

  • Table Product and Service Introduction of Alvizia Health Care

  • Table Company Profile and Development Status of Bayer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

  • Figure Sales and Growth Rate Analysis of Bayer

  • Figure Revenue and Market Share Analysis of Bayer

  • Table Product and Service Introduction of Bayer


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top